tetrandrine has been researched along with Nasopharyngeal Carcinoma in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Bao, H; Chang, L; Lai, X; Li, S; Li, Y; Wang, J; Yao, Z; Zhang, G | 1 |
| Chang, L; Huang, J; Huang, Z; Lai, X; Li, X; Wang, J; Wang, Z; Zhang, G | 1 |
| Chang, L; Daqing, L; Li, J; Wang, J; Wang, K; Wu, X; Zhang, G; Zhuang, S | 1 |
3 other study(ies) available for tetrandrine and Nasopharyngeal Carcinoma
| Article | Year |
|---|---|
Tetrandrine sensitizes nasopharyngeal carcinoma cells to irradiation by inducing autophagy and inhibiting MEK/ERK pathway.
Topics: Animals; Apoptosis; Autophagy; Benzylisoquinolines; Cell Line, Tumor; Cell Proliferation; Extracellular Signal-Regulated MAP Kinases; Female; Humans; MAP Kinase Kinase Kinases; Mice, Inbred BALB C; Mice, Nude; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Phosphorylation; Radiation-Sensitizing Agents; Signal Transduction; Tumor Burden; Xenograft Model Antitumor Assays | 2020 |
Tetrandrine enhances radiosensitivity through the CDC25C/CDK1/cyclin B1 pathway in nasopharyngeal carcinoma cells.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Benzylisoquinolines; Caspase 3; CDC2 Protein Kinase; cdc25 Phosphatases; Cell Line, Tumor; Cyclin B1; DNA Breaks, Double-Stranded; G2 Phase Cell Cycle Checkpoints; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Radiation Tolerance; Radiation, Ionizing; Signal Transduction | 2018 |
[Effects of tetrandrine on enhancing radiosensitivity of human nasopharyngeal carcinoma cells].
Topics: Apoptosis; Benzylisoquinolines; Carcinoma; Cell Line, Tumor; DNA Repair; Humans; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Metastasis; Radiation Tolerance | 2014 |